ANTONIO CASADO HERRÁEZ-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling (Breast Cancer Research and Treatment, (2018), 171, 3, (627-634), 10.1007/s10549-018-4855-2)

    Breast Cancer Research and Treatment

  2. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

    Breast Cancer Research and Treatment, Vol. 171, Núm. 3, pp. 627-634

2011

  1. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

    Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136

  2. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review

    Clinical and Translational Oncology, Vol. 13, Núm. 2, pp. 121-132

2009

  1. Circulating tumor cells in metastatic breast cancer: Timing of blood extraction for analysis

    Anticancer Research, Vol. 29, Núm. 10, pp. 4185-4187

2006

  1. Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma

    Clinical and Translational Oncology, Vol. 8, Núm. 9, pp. 676-680

2005

  1. Trastuzumab associated with successive cytotoxic therapies beyond disease progression in metastatic breast cancer

    Clinical Breast Cancer, Vol. 6, Núm. 4, pp. 325-329